Tokyo, Jan. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060295) titled 'Evaluation of the efficacy of switching from a xanthine oxidase inhibitor (febuxostat) to a selective urate reabsorption inhibitor (dotinurad) in patients with hyperuricemia and chronic kidney disease (CKD)' on Jan. 8.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - NHO Higashihiroshima Medical Center
Condition:
Condition - Hyperuricemia with chronic kidney disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Xanthine oxidase ...